Moscatilin Induces Ferroptosis in Clear Cell Renal Cell Carcinoma via the JAK – STAT Signaling Pathway
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Pei Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zunyi Medical University, Zunyi, Guizhou, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Ferroptosis, Kidney Neoplasms, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Chengdu University Affiliated Hospital Climbing Talent Program, and the Innovation Team Project of Affiliated Hospital of Clinical School of Medicine of Chengd…, Sichuan Medical (Youth Innovative) Scientific Research Projects, research projects from Chengdu Science and Technology.
Abstract (Originalsprache)
Moscatilin, a biphenyl compound derived from Dendrobium nobile , exhibits significant anti‐tumor activity. However, the specific role of moscatilin in clear cell renal cell carcinoma (ccRCC) and its underlying molecular mechanisms have not been fully studied. This study aims to fill this gap by demonstrating through a series of experiments that moscatilin can effectively inhibit the proliferation and migration of ccRCC and induce its apoptosis process. More importantly, we found that moscatilin can also trigger ferroptosis in ccRCC, a process accompanied by significant increases in Fe 2+ , MDA (a lipid peroxidation product), and ROS (reactive oxygen species) levels, as well as decreases in mitochondrial membrane potential and GSH (glutathione) levels. These changes strongly suggest a key role for moscatilin in inducing ferroptosis. To further explore its underlying mechanism, we speculate that moscatilin may inhibit the phosphorylation level of the JAK–STAT signaling pathway, thereby blocking the function of the key protein SLC7A11 in the ferroptosis signaling pathway, which promotes the occurrence of ferroptosis. This discovery not only reveals a new mechanism of moscatilin in the treatment of ccRCC but also provides new ideas for the development of related drugs in the future. In summary, based on the important discovery that moscatilin can induce ferroptosis in ccRCC, we have reason to believe that moscatilin has the potential to become a new type of drug for the treatment of ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Zunyi Medical University, Zunyi, Guizhou, China.
- Department of Urology, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
- Department of Urology, The Fifth Hospital of DeYang, DeYang, China.
- Department of Urology, the Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, China.
ORCID-Profile: Pei Chen
Förderung
- Chengdu University Affiliated Hospital Climbing Talent Program, and the Innovation Team Project of Affiliated Hospital of Clinical School of Medicine of Chengd…
- Sichuan Medical (Youth Innovative) Scientific Research Projects
- research projects from Chengdu Science and Technology
- Natural Science Foundation from the Department of Science and Technology of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, P., Yang, J., Chen, L., Liu, C., Li, Z., Long, X., Wu, J., Wu, B., & Wu, J. (2025). Moscatilin Induces Ferroptosis in Clear Cell Renal Cell Carcinoma via the JAK – STAT Signaling Pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70071
Vancouver
Chen P, Yang J, Chen L, Liu C, Li Z, Long X, et al. Moscatilin Induces Ferroptosis in Clear Cell Renal Cell Carcinoma via the JAK – STAT Signaling Pathway. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70071
BibTeX
@article{Chen2025,
author = {Chen, Pei and Yang, Jin and Chen, Lin and Liu, Chenhuan and Li, Zhihao and Long, Xiaoming and Wu, Jinbang and Wu, Bo and Wu, Jianjun},
title = {Moscatilin Induces Ferroptosis in Clear Cell Renal Cell Carcinoma via the JAK – STAT Signaling Pathway},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70071}
}
EUVIMED